Showing results (171-180 of 181) with videos related to
Sort By:
Pageof 19
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 13, 2021
Therapeutic effect of a novel curcumin derivative GT863 on a mouse model of amyotrophic lateral sclerosisHajime Kato, Hiroyasu Sato, Michiaki Okuda, et al.Nature Communications|March 14, 2025
PNPLA6 regulates retinal homeostasis by choline through phospholipid turnoverTakashi Ono, Yoshitaka Taketomi, Takayoshi Higashi, et al.Cell Metabolism|June 10, 2014
The adipocyte-inducible secreted phospholipases PLA2G5 and PLA2G2E play distinct roles in obesityHiroyasu Sato, Yoshitaka Taketomi, Ayako Ushida, et al.No to Shinkei = Brain and Nerve|February 26, 2005
[An outbreak of encephalopathy after eating autumn mushroom (Sugihiratake; Pleurocybella porrigens) in patients with renal failure: a clinical analysis of ten cases in Yamagata, Japan]Takeo Kato, Toru Kawanami, Hiroshi Shimizu, et al.Plos One|November 19, 2016
A Segmental Copy Number Loss of the SFMBT1 Gene Is a Genetic Risk for Shunt-Responsive, Idiopathic Normal Pressure Hydrocephalus (iNPH): A Case-Control StudyHidenori Sato, Yoshimi Takahashi, Luna Kimihira, et al.BMC Genetics|April 18, 2014
A gain-of-function screen to identify genes that reduce lifespan in the adult of Drosophila melanogasterMinoru Nakayama, Tomoki Ishibashi, Hiroyuki O Ishikawa, et al.Organic Letters|August 8, 2025
Genome Mining-Based Discovery of Pyrano[2,3-<i>c</i>]pyrrole Type Natural Products Possessing Alkyl Side Chain with Branched Methyl GroupsYue Shi, Taro Ozaki, Yohei Morishita, et al.Cell Reports|January 31, 2023
Hepatic phosphatidylcholine catabolism driven by PNPLA7 and PNPLA8 supplies endogenous choline to replenish the methionine cycle with methyl groupsTetsuya Hirabayashi, Mai Kawaguchi, Sayaka Harada, et al.Nature Immunology|April 30, 2013
Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axisYoshitaka Taketomi, Noriko Ueno, Takumi Kojima, et al.Geriatrics & Gerontology International|December 30, 2015
Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's diseaseKatsutoshi Furukawa, Naoki Tomita, Daisuke Uematsu, et al.Pageof 19